Items Tagged ‘paclitaxel’

February 5, 2015

Afinitor® plus Herceptin® and Paclitaxel Effective in Advanced Hormone Receptor-Negative HER2-Positive Breast Cancer


The combination of Afinitor® (everolimus) plus Herceptin® (trastuzumab) paclitaxel appears effective for patients with advanced HER2-positive breast cancer that is hormone receptor (HR)-negative. These findings were presented at the 2014 San Antonio Breast Cancer Symposium, December 9–13, in San Antonio, Texas. Afinitor is an oral medication that works by inhibiting a protein known as mTOR. […]

View full entry

Tags: afinitor, Breast Cancer, herceptin, paclitaxel